{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:35:13Z","timestamp":1758893713692,"version":"3.43.0"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>Keratinocyte cancer (KC) cases have risen by 172% in Denmark over the last decade and the lifetime risk of developing KC is at least 22%. This highlights the need for innovative strategies in KC prevention, diagnosis, and treatment. To reduce incidence, new prevention methods are crucial. New diagnostics using non-invasive scanning can streamline patient care, especially for low-risk tumours and patients with multiple tumours. New treatments can be more effective and with fewer side effects. Together, these initiatives can improve the patient journey and ease the burden on healthcare resources, as argued in this review.<\/jats:p>","DOI":"10.61409\/v10240733","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T06:32:37Z","timestamp":1743575557000},"page":"1-8","source":"Crossref","is-referenced-by-count":1,"title":["Keratinocyte cancer"],"prefix":"10.61409","author":[{"given":"Emilie Westerlin","family":"Kjeldsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinzent Kevin","family":"Ortner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kathrine","family":"Rossau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Vinding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"S\u00f8lvsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine","family":"Togsverd-Bo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Pallesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bjerring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trine","family":"H\u00f8gsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrikke","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merete","family":"H\u00e6dersdal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Sieborg J, Haedersdal M, Lei U et al. Incidence and geographic differences in keratinocyte carcinoma and Bowen's disease in office\u2010based dermatological practice between 2013 and 2022: a nationwide Danish registry\u2010based study. JEADV Clin Pract. 2024;3(4):1164-74. https:\/\/doi.org\/10.1002\/jvc2.478","DOI":"10.1002\/jvc2.478"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Holm AS, Nissen C V, Wulf HC. Basal cell carcinoma is as common as the sum of all other cancers: implications for treatment capacity. Acta Derm Venereol. 2016;96(4):505-9. https:\/\/doi.org\/10.2340\/00015555-2282","DOI":"10.2340\/00015555-2282"},{"key":"ref2","unstructured":"RKKP. Hudkr\u00e6ftdatabasen. NMSC \u00e5rsrapport 2023\/2024. RKKP, 2024. https:\/\/rkkp-data.dk\/aarsrapporter\/nmsc\/ (jan 2025)"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Urban K, Mehrmal S, Uppal P et al. The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990-2017. JAAD Int. 2021;2:98-108. https:\/\/doi.org\/10.1016\/j.jdin.2020.10.013","DOI":"10.1016\/j.jdin.2020.10.013"},{"key":"ref4","unstructured":"Kr\u00e6ftens Bek\u00e6mpelse. Statistik om basalcelle- og pladecellekr\u00e6ft samlet (hudkr\u00e6ft). Kr\u00e6ftens Bek\u00e6mpelse, 2024. www.cancer.dk\/hudkraeft-hudcancer\/fakta\/statistik\/basalcellekraeft-pladecellekraeft-samlet\/ (22. okt 2024)"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol. 2011;65(2):253-261. https:\/\/doi.org\/10.1016\/j.jaad.2010.11.062","DOI":"10.1016\/j.jaad.2010.11.062"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Peris K, Fargnoli MC, Kaufmann R et al. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma - update 2023. Eur J Cancer. 2023;192:113254. https:\/\/doi.org\/10.1016\/j.ejca.2023.113254","DOI":"10.1016\/j.ejca.2023.113254"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Stratigos AJ, Garbe C, Dessinioti C et al. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: part 2. Treatment -update 2023. Eur J Cancer. 2023;193:113252. https:\/\/doi.org\/10.1016\/j.ejca.2023.113252","DOI":"10.1016\/j.ejca.2023.113252"},{"key":"ref8","unstructured":"H\u00e6dersdal M, Mosegaard M, Lamberg A et al. Guidelines vedr\u00f8rende behandling af basalcellecarcinomer. Dansk Dermatologisk Selskab, 2019. https:\/\/dds.nu\/wp-content\/uploads\/2019\/03\/DDS-Guidelines-BCC_Final_2019.02.26.pdf (jan 2025)"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Bentzen J, Kjellberg J, Thorgaard C et al. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark. Eur J Cancer Prev. 2013;22(6):569-76. https:\/\/doi.org\/10.1097\/CEJ.0b013e328360150c","DOI":"10.1097\/CEJ.0b013e328360150c"},{"key":"ref10","unstructured":"Sundhedsstyrelsen. Solbeskyttelse. Sundhedsstyrelsen, 2024. http:\/\/www.sst.dk\/da\/Borger\/Straaling_-miljoe-og-klima\/Vejr-og-klima\/Solbeskyttelse% (21. okt 2024)"},{"key":"ref11","unstructured":"Kr\u00e6ftens Bek\u00e6mpelse. Danskernes solarievaner 2022. Solkampagnen. Kr\u00e6ftens Bek\u00e6mpelse, 2022. https:\/\/mediebibliotek.cancer.dk\/m\/5c22cd6862c7211e\/original\/Danskernes-solarievaner-2022.pdf (jan 2025)"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ. 2012;345:e4757. https:\/\/doi.org\/10.1136\/bmj.e4757","DOI":"10.1136\/bmj.e4757"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Gordon LG, Sinclair C, Cleaves N et al. Consequences of banning commercial solaria in 2016 in Australia. Health Policy. 2020;124(6):665-670. https:\/\/doi.org\/10.1016\/j.healthpol.2020.04.010","DOI":"10.1016\/j.healthpol.2020.04.010"},{"key":"ref14","unstructured":"WHO. National regulations on access and control of sunbeds by country. WHO, 2021. https:\/\/apps.who.int\/gho\/data\/view.main.SUNBEDACCESSANDCONTROLv (21. okt 2024)"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Chen AC, Martin AJ, Choy B et al. A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618-26. https:\/\/doi.org\/10.1056\/NEJMoa1506197","DOI":"10.1056\/NEJMoa1506197"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Pihl C, Andersen F, Bjerring P et al. Efficacy of combinational treatment versus nicotinamide monotherapy in the prevention of ultraviolet radiation-induced skin cancer. Dermatology. 2024;240(3):453-461. https:\/\/doi.org\/10.1159\/000538445","DOI":"10.1159\/000538445"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Allen NC, Martin AJ, Snaidr VA et al. Nicotinamide for skin-cancer chemoprevention in transplant recipients. N Engl J Med. 2023;388(9):804-812. https:\/\/doi.org\/10.1056\/NEJMoa2203086","DOI":"10.1056\/NEJMoa2203086"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Togsverd-Bo K, Omland SH, Wulf HC et al. Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial. Am J Transplant. 2015;15(11):2986-90. https:\/\/doi.org\/10.1111\/ajt.13358","DOI":"10.1111\/ajt.13358"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Benson TA, Hibler BP, Kotliar D, Avram M. Nonablative fractional laser treatment is associated with a decreased risk of subsequent facial keratinocyte carcinoma development. Dermatol Surg. 2023;49(2):149-154. https:\/\/doi.org\/10.1097\/DSS.0000000000003672","DOI":"10.1097\/DSS.0000000000003672"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Olesen UH, Jacobsen K, Lerche CM, Haedersdal M. Repeated exposure to fractional CO2 laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line-field confocal optical coherence tomography and histology. Lasers Surg Med. 2023;55(1):73-81. https:\/\/doi.org\/10.1002\/lsm.23613","DOI":"10.1002\/lsm.23613"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Nichols AJ, Allen AH, Shareef S et al. Association of human papillomavirus vaccine with the development of keratinocyte carcinomas. JAMA Dermatol. 2017;153(6):571-574. https:\/\/doi.org\/10.1001\/jamadermatol.2016.5703","DOI":"10.1001\/jamadermatol.2016.5703"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Rajadhyaksha M, Marghoob A, Rossi A et al. Reflectance confocal microscopy of skin in vivo: from bench to bedside. Lasers Surg Med. 2017;49(1):7-19. https:\/\/doi.org\/10.1002\/lsm.22600","DOI":"10.1002\/lsm.22600"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Reiter O, Mimouni I, Gdalevich M et al. The diagnostic accuracy of dermoscopy for basal cell carcinoma: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1380-1388. https:\/\/doi.org\/10.1016\/j.jaad.2018.12.026","DOI":"10.1016\/j.jaad.2018.12.026"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Cinotti E, Brunetti T, Cartocci A et al. Diagnostic accuracy of line-field confocal optical coherence tomography for the diagnosis of skin carcinomas. Diagnostics (Basel). 2023;13(3):361. https:\/\/doi.org\/10.3390\/diagnostics13030361","DOI":"10.3390\/diagnostics13030361"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Gust C, Schuh S, Welzel J et al. Line-field confocal optical coherence tomography increases the diagnostic accuracy and confidence for basal cell carcinoma in equivocal lesions: a prospective study. Cancers (Basel). 2022;14(4):1082. https:\/\/doi.org\/10.3390\/cancers14041082","DOI":"10.3390\/cancers14041082"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Jacobsen K, Ortner VK, Wenande E et al. Interobserver agreement on line-field confocal optical coherence tomography image markers in keratinocyte carcinomas and precursor lesions. Arch Dermatol Res. 2024;316(8):608. https:\/\/doi.org\/10.1007\/s00403-024-03344-y","DOI":"10.1007\/s00403-024-03344-y"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Holm KBE, Nielsen LJ, Lock-Andersen J et al. Optical coherence tomography for presurgical delineation of basal cell carcinomas on the face - a comparison with histopathology. J Cutan Pathol. 2023;50(5):441-449. https:\/\/doi.org\/10.1111\/cup.14412","DOI":"10.1111\/cup.14412"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Wenande E, Hendel K, Mogensen M et al. Efficacy and safety of laser-assisted combination chemotherapy: an explorative imaging-guided treatment with 5-fluorouracil and cisplatin for basal cell carcinoma. Lasers Surg Med. 2021;53(1):119-128. https:\/\/doi.org\/10.1002\/lsm.23323","DOI":"10.1002\/lsm.23323"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Steeb T, Schlager JG, Kohl C et al. Laser-assisted photodynamic therapy for actinic keratosis: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(4):947-956. https:\/\/doi.org\/10.1016\/j.jaad.2018.09.021","DOI":"10.1016\/j.jaad.2018.09.021"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:54:22Z","timestamp":1754484862000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V10240733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v10240733","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,3,31]]}}}